Skip to Main Content
Kyle Blackburn, M.D.

Kyle Blackburn, M.D.

Assistant Professor

School
Medical School
Department
Neurology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Biography

    Joined UT Southwestern: 2020

    Clinical Interests: Dr. Blackburn sees patients in the Multiple Sclerosis and Neuroimmunology Clinic in the Aston Ambulatory Care Center. He specializes in the diagnosis and treatment of rare autoimmune neurological disorders, including autoimmune encephalitis, stiff person syndrome, paraneoplastic neurological syndromes, and neurosarcoidosis.

    Research: His research focuses on developing new treatments and identifying new markers of disease activity in autoimmune neurological disorders to optimize management for these rare disorders. 

    Education Activities: He is dedicated to resident fellow and serves as Program Director for the Neuroimmunology Fellowship, and Associate Program Director for the Adult Neurology Residency

  • Education
    Medical School
    University of Kentucky College of Medicine (2014)
    Residency
    University of Texas Southwestern Medical School (2018), Neurology
    Fellowship
    UT Southwestern Medical Center (2020), Autoimmune Neurology
  • Research Interest
    • Autoantibodies in Neurological Disorders
    • Autoimmune Encephalitis
    • Clinical Trials in Rare Disorders
    • Neuromyelitis Optica
    • Neurosarcoidosis
    • Paraneoplastic Neurological Syndromes
    • Stiff Person Syndrome
  • Publications
    Generative artificial intelligence versus clinicians: Who diagnoses multiple sclerosis faster and with greater accuracy?
    Patel MA, Villalobos F, Shan K, Tardo LM, Horton L, Sguigna PV, Blackburn KM, Munoz SB, Moog TM, Smith AD, Burgess KW, McCreary M, Okuda DT Multiple Sclerosis and Related Disorders 2024 Oct 90
    Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design
    Sguigna PV, Hussain RZ, Okai A, Blackburn KM, Tardo L, Madinawala M, Korich J, Lebson LA, Kaplan J, Salter A, Manouchehri N, Stuve O Therapeutic Advances in Neurological Disorders 2024 Jan 17
    Hero or Antagonist: A Case Series on the Tolerability of Memantine as Salvage Therapy for Catatonia from Anti-NMDA Receptor Encephalitis
    Maneta EK, Wang J, Abu-Hamad SJ, Jennings M, Blackburn K, Robinson DM Harvard review of psychiatry 2023 Nov 31 281-286
    VH2+ Antigen-Experienced B Cells in the Cerebrospinal Fluid Are Expanded and Enriched in Pediatric Anti-NMDA Receptor Encephalitis
    Monson N, Smith C, Greenberg H, Plumb P, Guzman A, Tse K, Chen D, Zhang W, Morgan M, Speed H, Powell C, Batra S, Cowell L, Christley S, Vernino S, Blackburn K, Greenberg B Journal of Immunology 2023 Nov 211 1332-1339
    A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis
    Tardo L, Salter A, Truong-Le M, Horton L, Blackburn KM, Sguigna PV Therapeutic Advances in Chronic Disease 2023 Jan 14
    Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective study
    Sguigna PV, Toranian S, Tardo LM, Blackburn KM, Horton LA, Conger D, Meltzer E, Hogan RN, McCreary M, Zee PC, Takahashi JS, Greenberg BM Multiple Sclerosis Journal - Experimental, Translational and Clinical 2023 Jan 9
    Autoimmune Encephalitis Misdiagnosis in Adults
    Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR JAMA neurology 2023 Jan 80 30-39
    Clinical Reasoning: A 59-Year-Old Man with Thymoma and Constitutional Symptoms, Seizures, and Multifocal CNS Lesions
    Stopschinski BE, Fredrich S, Vernino S, Phillips L, Blackburn KM Neurology 2022 Dec 99 1115-1121
    Refractory Anti-NMDA Receptor Encephalitis in Early Pregnancy: A Case Report of Treatment Course and Pregnancy Outcomes
    Fredrich S, Wang C, Narayan R, Tardo L, Blackburn KM, Vernino S Neurology: Neuroimmunology and NeuroInflammation 2022 Sep 9
    Low Recruitment in a Double-Blind, Placebo-Controlled Trial of Ocrelizumab for Autoimmune Encephalitis: A Case Series and Review of Lessons Learned
    Blackburn KM, Denney DA, Hopkins SC, Vernino SA Neurology and Therapy 2022 Jun 11 893-903
  • Honors & Awards
    • James T. Lubin Clinician Scientist Fellowship Award
      (2018-2020)
  • Professional Associations/Affiliations
    • American Academy of Neurology (2014)
    • American Neurological Association (2020)